ASLN — Aslan Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln
ASLAN Pharma up on antibody manufacturing pact with Thermo Fisher
Brief: Aslan Pharmaceuticals Ltd Files For Offering Of Up To $21.5 Mln Of ADS - SEC Filing
Jefferies bullish on Aslan's lead drug candidate potential, shares rise
U.S. RESEARCH ROUNDUP-Adagene, Costco Wholesale, Ulta Beauty
Brief: Aslan Pharmaceuticals Announces Pricing Of ADS Offering
ASLAN Pharma: Gains on approval to expand eczema treatment study
Brief: Aslan Pharma Receives Letter Confirming Co No Longer Considered Public In Taiwan
U.S. RESEARCH ROUNDUP-Brigham Minerals, Continental Resources, Square
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:39 AM
U.S. STOCKS ON THE MOVE-Bank stocks, Chip stocks, PG&E, DarioHealth, ViewRay
U.S. STOCKS ON THE MOVE-Chip and oil stocks, DarioHealth, Aslan Pharmaceuticals, Outlook Therapeutics
U.S. STOCKS ON THE MOVE-Chip stocks, Netflix, PG&E, Facebook, DarioHealth
U.S. STOCKS ON THE MOVE-Chip stocks, Netflix, PG&E, Aslan Pharmaceuticals, Axsome Therapeutics
Aslan Pharma drops on deep-discounted share offering
Aslan Pharma launches offering after stock more than doubles